Your browser doesn't support javascript.
loading
EBF3 reactivation by inhibiting the EGR1/EZH2/HDAC9 complex promotes metastasis via transcriptionally enhancing vimentin in nasopharyngeal carcinoma.
Ding, Shirong; Wang, Xin; Lv, Dongming; Tao, Yalan; Liu, Songran; Chen, Chen; Huang, Zilu; Zheng, Shuohan; Wei, Yinghong; Kang, Tiebang; Xia, Yunfei.
Afiliação
  • Ding S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China; Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, Guangzhou, China.
  • Wang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China; The Department of Liver Surgery, Sun Yat-sen University Cancer Centre, Guangzhou, China.
  • Lv D; Department of Burn and Plastic Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Tao Y; Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, Guangzhou, China.
  • Liu S; Department of Pathology, Sun Yat-sen University Cancer Centre, Guangzhou, China.
  • Chen C; Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, Guangzhou, China.
  • Huang Z; Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, Guangzhou, China.
  • Zheng S; Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, Guangzhou, China.
  • Wei Y; Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, Guangzhou, China.
  • Kang T; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. Electronic address: kangtb@sysucc.org.cn.
  • Xia Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China; Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, Guangzhou, China. Electronic address: xiayf@sysucc.org.cn.
Cancer Lett ; 527: 49-65, 2022 02 28.
Article em En | MEDLINE | ID: mdl-34906623
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Vimentina / Proteína Potenciadora do Homólogo 2 de Zeste / Carcinoma Nasofaríngeo Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cancer Lett Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Vimentina / Proteína Potenciadora do Homólogo 2 de Zeste / Carcinoma Nasofaríngeo Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cancer Lett Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China